IP Library › Granted Patent US 7,420,031
Granted Patent B2
US 7,420,031 · App. 11/318,535 · Granted Sep 2, 2008

Intracellular delivery of small molecules, proteins, and nucleic acids

Assignee: Lonza Walkersville, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,420,031
App. No.
11/318,535
Granted
Sep 2, 2008
Kind
B2
Abstract

An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.

Claims (7)

1. A complex comprising a cargo moiety complexed with polypeptide comprising a protein transduction domain (PTD) wherein said polypeptide is capable of complexing with said cargo moiety, wherein said cargo moiety is selected from the group consisting of an immortalization protein, an anti-apoptotic protein, and an antibody, wherein the PTD comprises Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) and wherein the complex can traverse a cellular membrane.

2. The complex of claim 1 wherein the cargo moiety is an immortalization protein, wherein the immortalization protein is selected from the group consisting of SV40 large T antigen and telomerase.

3. The complex of claim 1 wherein the cargo moiety is an anti-apoptotic protein, wherein the anti-apoptotic protein is selected from the group consisting of mutant p53 and Bcl x L.

4. The complex of claim 1 wherein said polypeptide comprising said PTD is a fusion protein.

5. A conjugate comprising a polypeptide with a protein transduction domain (PTD) linked to a cargo moiety, wherein said cargo moiety is selected from the group consisting of an immortalization protein, an anti-apoptotic protein, and an antibody, wherein the PTD comprises Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1), and wherein the conjugate can traverse a cellular membrane.

6. The conjugate of claim 5 wherein the cargo moiety is an immortalization protein, wherein the immortalization protein is selected from the group consisting of SV40 large T antigen and telomerase.

7. The conjugate of claim 5 wherein the cargo moiety is an anti-apoptotic protein, wherein the anti-apoptotic protein is selected from the group consisting of mutant p53 and Bcl x L.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2008
From: KARAS, MICHAEL
To: BIOWHITTAKER TECHNOLOGIES, INC.
Reel/Frame 020672/0337 →
CHANGE OF NAME Recorded Mar 19, 2008
From: BIOWHITTAKER TECHNOLOGIES, INC.
To: LONZA BIOSCIENCE TECHNOLOGIES, INC.
Reel/Frame 020672/0406 →
MERGER Recorded Mar 19, 2008
From: LONZA BIOSCIENCE TECHNOLOGIES, INC.
To: LONZA WALKERSVILLE, INC.
Reel/Frame 020672/0436 →
CHANGE OF NAME Recorded Mar 6, 2008
From: CAMBREX BIO SCIENCE WALKERSVILLE INC.
To: LONZA WALKERSVILLE INC.
Reel/Frame 020608/0247 →
Continuity (3)
Division 1079076800 · Mar 3, 2004
Provisional Application 6045124300 · Mar 4, 2003
Related Publication 20060106197A1 · May 18, 2006